Freenome Stock

freenome.comBioTechFounded: 2014Funding to Date: $1.1B

Freenome is a biotechnology company driven to provide the tools needed to detect, treat and prevent cancer using routing blood draw. This company was founded in 2014 by Gabe Otte, Riley Ennis, Charles Roberts and is headquartered in South San Francisco, CA. Freenome combines molecular biology with advanced computational biology and machine learning to help with early cancer detection.

Register for Details

For more details on financing and valuation for Freenome, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Freenome.

Register Today

Freenome investors also invested in these private companies

Team

Management Team

Mike Nolan
Co-Founder & Chief Executive Officer
Riley Ennis
Co-Founder & Chief Technology Officer
Charles Roberts
Co-Founder & Chief Growth Officer

Board Members

William Grady, MD
Fred Hutchinson Cancer Research Center
Alberto Gutierrez, PhD
NDA Partners
Daniel F Hayes, MD
University of Michigan
Douglas Robertson, MD
White River Junction Veterans Affairs Medical Center
Sherie Smalley, MD
AlohaCare

Other companies like Freenome in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.3B
Sector
Last Round Est. Valuation
$3.1B
Sector
Last Round Est. Valuation
$5.81B
Sector
Last Round Est. Valuation
$1.2B
Sector
Last Round Est. Valuation
$1.6B
Sector
Last Round Est. Valuation
$1.61B